$110.17+0.65%Close 16 Nov 2026 · Market value $13.15B
In its results release of 2 Nov 2026 (Q1 FY2027), Clorox gave 6 forecasts in figures, among them EPS of $5.41 to $5.71 for FY2027. Over the last two years, results landed above the company's own last range 0 of 3 times, within it 2 and below it 1.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q1 FY2027 results, 2 Nov 2026
| Measure | Period | Guidance | As stated |
|---|
| EPS | FY2027 | $5.41 to $5.71 | Diluted EPS is still expected to be between $5.41 and $5.71, a year-over-year increase of 12% to 19%, respectively |
|---|
| EPS growth | FY2027 | +12% to +19% | Diluted EPS is still expected to be between $5.41 and $5.71, a year-over-year increase of 12% to 19%, respectively |
|---|
| EPS · Adjusted | FY2027 | $5.70 to $6.00 | Adjusted EPS is still expected to be between $5.70 and $6.00, or an increase between 3% and 8%, respectively |
|---|
| EPS growth · Adjusted | FY2027 | +3% to +8% | Adjusted EPS is still expected to be between $5.70 and $6.00, or an increase between 3% and 8%, respectively |
|---|
| Gross margin | FY2027 | About 41.5% | Gross margin is now expected to be about 41.5%, reflecting higher-than-normal inflationary headwinds and negative mix more than offsetting the benefits from cost savings and pricing actions |
|---|
| Tax rate | FY2027 | About 23% | The company's effective tax rate is still expected to be about 23%. |
|---|
Source: the company's earnings release.
Guidance against results above 0 · within 2 · below 1
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| EPS | FY2027 | $5.41 to $5.71 | Unchanged | — | To come |
|---|
| EPS growth | FY2027 | +12% to +19% | Unchanged | — | To come |
|---|
| EPS · Adjusted | FY2027 | $5.70 to $6.00 | Unchanged | — | To come |
|---|
| EPS growth · Adjusted | FY2027 | +3% to +8% | Unchanged | — | To come |
|---|
| Gross margin | FY2027 | About 41.5% | Lowered once | — | To come |
|---|
| Tax rate | FY2027 | About 23% | Unchanged | — | To come |
|---|
| Revenue growth | FY2026 | About −6% | Raised once | −5.41% | Above the range |
|---|
| EPS · Adjusted | FY2026 | $5.45 to $5.65 | Lowered once | $5.54 | Within the range |
|---|
| Tax rate | FY2026 | About 24% | Unchanged | 24.02% | Within the range |
|---|
| Revenue growth | FY2025 | −2% to −1% | Given once | +0.16% | Above the range |
|---|
| Tax rate | FY2025 | About 26% | Lowered once | 23.56% | Below the range |
|---|
CLX in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.